Humanigen Inc logo

Humanigen Inc

OTCPK:HGENQ (USA)  
$ 0.00 -0.000299 (-99.67%) 11:09 PM EST
At Loss
Market Cap:
$ 36.00K
Enterprise V:
$ -21.66M
Volume:
-
Avg Vol (2M):
30.05K
Also Trade In:
Volume:
-
At Loss
Avg Vol (2M):
30.05K

Business Description

Description
Humanigen Inc is a biopharmaceutical company engaged in the development of proprietary monoclonal antibodies for various oncology indications and to enhance T-cell therapies, making these treatments safer and cost-effective. It focuses on preventing the serious and potentially life-threatening side effects associated with chimeric antigen receptor T-cell (CAR-T) therapy. Its pipeline includes programs such as Lenzilumab, Ifabotuzumab, and HGen005. It has one segment, which is related to the development of pharmaceutical products.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.12
Equity-to-Asset -9.72
Debt-to-Equity -0.51
Debt-to-EBITDA -0.49
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -231.89
Distress
Grey
Safe
Beneish M-Score 9.16
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 68.82
9-Day RSI 64.81
14-Day RSI 59.86
6-1 Month Momentum % -98.9
12-1 Month Momentum % -99.93

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.09
Quick Ratio 0.09
Cash Ratio 0.06

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -73.5
Shareholder Yield % -199525

Profitability Rank

Name Current Vs Industry Vs History
Operating Margin % -3061.21
Net Margin % -3156.8
FCF Margin % -3785.46
ROA % -164.47
ROIC % -1960.72

Financials (Next Earnings Date:2024-05-15 Est.)

HGENQ's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:HGENQ

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Humanigen Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1.699
EPS (TTM) ($) -0.54
Beta 1.26
Volatility % 136.76
14-Day RSI 59.86
14-Day ATR ($) 0.000067
20-Day SMA ($) 0.000136
12-1 Month Momentum % -99.93
52-Week Range ($) 0.00001 - 0.207
Shares Outstanding (Mil) 119.08

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Humanigen Inc Filings

Filing Date Document Date Form
No Filing Data

Humanigen Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Humanigen Inc Frequently Asked Questions

What is Humanigen Inc(HGENQ)'s stock price today?
The current price of HGENQ is $0.00. The 52 week high of HGENQ is $0.21 and 52 week low is $0.00.
When is next earnings date of Humanigen Inc(HGENQ)?
The next earnings date of Humanigen Inc(HGENQ) is 2024-05-15 Est..
Does Humanigen Inc(HGENQ) pay dividends? If so, how much?
Humanigen Inc(HGENQ) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1